It is now well known that non-coding RNAs (ncRNAs), rather than protein-coding transcripts,
are the preponderant RNA transcripts. NcRNAs, particularly microRNAs (miRNAs), long non …

Cancer is a daunting global problem confronting the world's population. The most frequent
therapeutic approaches include surgery, chemotherapy, radiotherapy, and more recently …

Differently expressed microRNAs (miRNAs) in the plasma of lung adenocarcinoma (LA)
patients might serve as biomarkers for LA detection. MiRNA expression profiling was …

MicroRNAs (miRNAs) are non-coding small RNAs that are master regulators of genic
expression and consequently of many cellular processes. But their expression is often …

Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases,
and it is one of the leading causes of cancer death in both men and women worldwide due …

Lung cancer remains the number one cause of cancer-related deaths worldwide with
221,200 estimated new cases and 158,040 estimated deaths in 2015. Approximately 80% of …

Background With persistent inconsistencies in colorectal cancer (CRC) miRNAs expression
data, it is crucial to shift toward inclusion of a “pre-laboratory” integrated analysis to expedite …

MicroRNAs (miRNAs) are small and highly conserved non‐coding RNAs that silence target
mRNAs, and compelling evidence suggests that they play an essential role in the …

Lung cancer is the most common cancer worldwide. Up to 85% of lung cancer cases are
diagnosed as non-small cell lung cancer (NSCLC). The effectiveness of NSCLC treatment is …

The introduction of EGFR-tyrosine kinase inhibitors (TKIs) has revolutionized the treatment
and prognosis of non-small cell lung cancer (NSCLC) patients harboring epidermal growth …